239 related articles for article (PubMed ID: 12865039)
41. Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.
Ruilope LM; Agarwal R; Chan JC; Cooper ME; Gansevoort RT; Haller H; Remuzzi G; Rossing P; Schmieder RE; Nowack C; Ferreira AC; Pieper A; Kimmeskamp-Kirschbaum N; Bakris GL
Am J Nephrol; 2014; 40(6):572-81. PubMed ID: 25591469
[TBL] [Abstract][Full Text] [Related]
42. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
43. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
[TBL] [Abstract][Full Text] [Related]
44. Dual blockade of the renin-angiotensin system in diabetic nephropathy: a randomized double-blind crossover study.
Rossing K; Christensen PK; Jensen BR; Parving HH
Diabetes Care; 2002 Jan; 25(1):95-100. PubMed ID: 11772908
[TBL] [Abstract][Full Text] [Related]
45. Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
Bakris GL; Toto RD; McCullough PA; Rocha R; Purkayastha D; Davis P;
Kidney Int; 2008 Jun; 73(11):1303-9. PubMed ID: 18354383
[TBL] [Abstract][Full Text] [Related]
46. [Effect of lisinopril on progression of retinopathy and microalbuminuria in normotensive subjects with insulin-dependent diabetes mellitus].
Sjølie AK; Chaturvedi N; Fuller J
Ugeskr Laeger; 1999 Feb; 161(7):949-52. PubMed ID: 10051804
[TBL] [Abstract][Full Text] [Related]
47. Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Ansquer JC; Foucher C; Rattier S; Taskinen MR; Steiner G;
Am J Kidney Dis; 2005 Mar; 45(3):485-93. PubMed ID: 15754270
[TBL] [Abstract][Full Text] [Related]
48. Nondihydropyridine Calcium Channel Blockers for the Treatment of Proteinuria: A Review of the Literature.
Steuber TD; Lee J; Holloway A; Andrus MR
Ann Pharmacother; 2019 Oct; 53(10):1050-1059. PubMed ID: 30966785
[No Abstract] [Full Text] [Related]
49. How to protect the kidney in diabetic patients: with special reference to IDDM.
Mogensen CE
Diabetes; 1997 Sep; 46 Suppl 2():S104-11. PubMed ID: 9285510
[TBL] [Abstract][Full Text] [Related]
50. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
Ahmad J; Siddiqui MA; Ahmad H
Diabetes Care; 1997 Oct; 20(10):1576-81. PubMed ID: 9314638
[TBL] [Abstract][Full Text] [Related]
51. Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.
Hansen JF; Hagerup L; Sigurd B; Pedersen F; Mellemgaard K; Pedersen-Bjergaard O; Mortensen LS
Am J Cardiol; 1997 Mar; 79(6):738-41. PubMed ID: 9070551
[TBL] [Abstract][Full Text] [Related]
52. Preventing end-stage renal disease.
Mogensen CE
Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
[TBL] [Abstract][Full Text] [Related]
53. Effect of strict blood pressure control on proteinuria in renal patients treated with different antihypertensive drugs.
García de Vinuesa S; Luño J; Gómez-Campderá F; Ridao N; Sánchez M; Dall'Anese C; Valderrábano F
Nephrol Dial Transplant; 2001; 16 Suppl 1():78-81. PubMed ID: 11369828
[TBL] [Abstract][Full Text] [Related]
54. Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy.
Kuriyama S; Tomonari H; Tokudome G; Horiguchi M; Hayashi H; Kobayashi H; Ishikawa M; Hosoya T
Hypertens Res; 2002 Nov; 25(6):849-55. PubMed ID: 12484508
[TBL] [Abstract][Full Text] [Related]
55. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
Hughes DB; Britton ML
Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022
[TBL] [Abstract][Full Text] [Related]
56. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension.
Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P
J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930
[TBL] [Abstract][Full Text] [Related]
57. Prospective comparison of therapeutical attitudes in hypertensive type 2 diabetic patients uncontrolled on monotherapy. A randomized trial: the EDICTA study.
Ruilope LM; de la Sierra A; Moreno E; Fernández R; Garrido J; de la Figuera M; de la Cámara AG; Coca A; Luque-Otero M
J Hypertens; 1999 Dec; 17(12 Pt 2):1917-23. PubMed ID: 10703890
[TBL] [Abstract][Full Text] [Related]
58. A Prospective Noninterventional, Observational Study to Describe the Effectiveness and Safety of Trandolapril and Verapamil Single-Pill Combination in the Management of Patients with Hypertension and Type 2 Diabetes Mellitus: A Harvest TR Study.
Atalar E; Eskin F; Tugtekin HB; Karabulut A; Kanyilmaz S; Kirbiyik H; Ozyildiz AG
Biomed Res Int; 2020; 2020():2123601. PubMed ID: 32964020
[TBL] [Abstract][Full Text] [Related]
59. The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes.
Rubio-Guerra AF; Arceo-Navarro A; Vargas-Ayala G; Rodriguez-Lopez L; Lozano-Nuevo JJ; Gomez-Harper CT
Diabetes Care; 2004 Jul; 27(7):1688-91. PubMed ID: 15220247
[TBL] [Abstract][Full Text] [Related]
60. Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril.
Bauduceau B; Genès N; Chamontin B; Vaur L; Renault M; Etienne S; Marre M
Am J Hypertens; 1998 Sep; 11(9):1065-73. PubMed ID: 9752891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
